Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
HLA DRA Antibody (169-1B5.2), Novus Biologicals™

Mouse Monoclonal Antibody
$268.00 - $524.00
Specifications
Antigen | HLA DRA |
---|---|
Clone | 169-1B5.2 |
Concentration | 0.2 mg/mL |
Dilution | Flow Cytometry 0.5 - 1 ug/million cells in 0.1 ml, SDS-Page, Immunofluorescence 0.5 - 1.0 ug/ml |
Applications | Flow Cytometry, SDS-Page, Immunofluorescence |
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
NBP24504300
![]() |
Novus Biologicals
NBP2450430.02MG |
0.02 mg |
Each for $268.00
|
|
|||||
NBP24504301
![]() |
Novus Biologicals
NBP2450430.1MG |
0.1 mg |
Each for $524.00
|
|
|||||
NBP24504302
![]() |
Novus Biologicals
NBP2450430.2MG |
0.2 mg | N/A | N/A | N/A | ||||
Description
Ensure accurate, reproducible results in Flow Cytometry, Immunofluorescence
HLA DRA Monoclonal specifically detects HLA DRA in Human, Bovine, Feline samples. It is validated for Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunofluorescence.Specifications
HLA DRA | |
0.2 mg/mL | |
Flow Cytometry, SDS-Page, Immunofluorescence | |
Unconjugated | |
Mouse | |
Adaptive Immunity, Cell Biology, Diabetes Research, Immunology | |
10mM PBS and 0.05% BSA with 0.05% Sodium Azide | |
FLJ51114, histocompatibility antigen HLA-DR alpha, HLA class II histocompatibility antigen, DR alpha chain, HLA-DRA1, major histocompatibility complex, class II, DR alpha, MHC cell surface glycoprotein, MHC class II antigen DRA, MLRW | |
HLA-DRA | |
IgG2b κ | |
Protein A or G purified | |
This antibody detects a monomorphic general framework determinant of HLA-DR Class II antigen. It does not cross react with HLA-DP and HLA-DQ. HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36kDa alpha (heavy) chain and a 28kDa beta (light) chain. It is expressed on B-cells, activated T-cells, monocytes/macrophages, dendritic cells and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 molecules, HLA-DR is critical for efficient peptide presentation to CD4+ T cells. It is an excellent histiocytic marker in paraffin sections producing intense cytoplasmic staining. True histiocytic neoplasms are similarly positive. HLA-DR antigens also occur on a variety of epithelial cells and their corresponding neoplastic counterparts. |
169-1B5.2 | |
Flow Cytometry 0.5 - 1 ug/million cells in 0.1 ml, SDS-Page, Immunofluorescence 0.5 - 1.0 ug/ml | |
Monoclonal | |
Purified | |
RUO | |
Human, Bovine, Feline | |
P01903 | |
3122 | |
Human peripheral blood leukocytes | |
Primary | |
Store at 4C. |
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title